Ειδήσεις: OBESITY | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 07:07 breitbart.com

Exclusive – RX Border Defense’s Patsy Writesman on CCP’s Stranglehold on Skinny: FDA’s ‘Green List’ Surrendered GLP-1 Supply Chain to China

RX Border Defense Patsy Writesman FDA Green List GLP‑1 drugs China supply chain obesity medication

30/03 16:31 yahoo.com

Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio

Eli Lilly incretin GLP‑1 diabetes obesity stock performance

30/03 06:10 bloomberg.com

Innovent Biologics Bullish on China Obesity Drug Outlook

Innovent Biologics obesity drug China market pharmaceutical optimism regulatory support sales growth

29/03 04:29 breitbart.com

Exclusive–RX Border Defense Says Buyer Beware When It Comes to Cheap Chinese Drug Ingredients for Weight Loss

RX Border Defense cheap Chinese drug ingredients weight loss obesity crisis US consumer warning Senator Jim Banks

29/03 01:01 foxnews.com

Hormone therapy boosts weight loss drug results by 35% in women, study finds

hormone therapy tirzepatide postmenopausal weight loss GLP‑1 obesity menopause

28/03 21:38 timesofsandiego.com

El uso de los ‘medicamentos maravilla’ para bajar de peso se ha duplicado. Investigan sus beneficios

weight loss Ozempic Zepbound cell reprogramming Salk Institute PNAS

28/03 10:16 defenseworld.net

WAVE Life Sciences Shares Phase 1 WVE-007 Data Showing Visceral Fat Loss, Muscle Preservation Signal

WVE‑007 Phase 1 visceral fat loss muscle preservation GalNAc‑siRNA obesity therapy

28/03 09:19 sciencedaily.com

Scientists discover a hidden system that turns brown fat into a calorie burner

Brown fat SLIT3 calorie burning blood vessels nerve growth metabolic health

27/03 16:07 statnews.com

STAT+: China’s biotech boom is rewriting everything

NIH crackdown China biotech boom foreign subawards Wave Life Sciences obesity trial results drug development

27/03 16:07 statnews.com

STAT+: China’s biotech boom is rewriting everything

NIH crackdown China biotech boom foreign subawards Wave Life Sciences obesity trial results drug development

Loading...